EPEN-36. THE TREATMENT OUTCOME OF PAEDIATRIC SUPRATENTORIAL C11ORF95-RELA FUSED EPENDYMOMA: A COMBINED REPORT FROM E-HIT SERIES AND AUSTRALIAN NEW ZEALAND CHILDREN’S HAEMATOLOGY/ONCOLOGY GROUP

AIM: Advances in molecular classification of paediatric ependymoma have been pivotal in improving risk stratification and understanding of this disease. C11orf95-RELA fused supratentorial ependymoma (ST-EPN) have been reported to have a poor outcome, with 10-year overall survival (OS) of 49% and pro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Ng, Chia Huan, Obrecht, Denise, Buntine, Molly, Wells, Olivia, Campbell, Martin A, Bhatia, Kanika, Sullivan, Michael, Williams, Molly, Quang, Dong Anh Khuong, Kinross, Kathryn, White, Christine, Algar, Elizabeth, Witt, Hendrik, Schuller, Ulrich, Mynarek, Martin, Pietsch, Torsten, Gerber, Nicolas U, Benesch, Martin, Warmuth-Metz, Monika, Kortmann, Rolf, Bison, Brigitte, Taylor, Michael D, Ramaswamy, Vijay, Rutkowski, Stefan, Pfister, Stefan M, Jones, David T W, Gottardo, Nicholas G, Von Hoff, Katja, Pajtler, Kristian W, Hansford, Jordan R
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Ependymoma
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715172/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.171
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars